F
First Tracks Biotherapeutics Inc
NASDAQ:TRAX
First Tracks Biotherapeutics Inc
NASDAQ:TRAX
Price:
43.88
USD
0.64%
Market Closed
Market Cap:
$1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
First Tracks Biotherapeutics Inc
NASDAQ:TRAX
|
US |
|
P
|
Pinnacle Silver and Gold Corp
F:P9J
|
CA |
|
R
|
Rio Silver Inc
OTC:RYOOF
|
CA |
|
S
|
Scotch Creek Ventures Inc
OTC:SCVFF
|
CA |
|
M
|
Metalore Resources Ltd
OTC:MTLRF
|
CA |
|
Dynamic Group Holdings Ltd
ASX:DDB
|
AU |
|
W
|
Webuild SpA
F:IPJ1
|
IT |
|
D
|
Denali Therapeutics Inc
F:4DN
|
US |
|
Resouro Strategic Metals Inc
F:8TX
|
CA |
|
G
|
Gamania Digital Entertainment Co Ltd
TPEX:6180
|
TW |
Wall St Price Targets
TRAX Price Targets Summary
First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics Inc
Wall Street analysts forecast TRAX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TRAX is 54.79 USD with a low forecast of 44.44 USD and a high forecast of 73.5 USD.
Lowest Forecast
Price Target
44.44
USD
1% Upside
Average Forecast
Price Target
54.79
USD
25% Upside
Highest Forecast
Price Target
73.5
USD
68% Upside
First Tracks Biotherapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TRAX's stock price target?
Price Target
54.79
USD
54.79
USD
According to Wall Street analysts, the average 1-year price target for TRAX is 54.79 USD with a low forecast of 44.44 USD and a high forecast of 73.5 USD.
